Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.

Saved in:
Bibliographic Details
Title: Entrectinib demonstrates prolonged efficacy in an adult case of radiation-refractory NTRK fusion glioblastoma.
Authors: Grogan PT; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA., Deming DA; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA., Helgager J; Department of Pathology and Laboratory Medicine, University of Wisconsin, Madison, Wisconsin, USA., Ruszkiewicz T; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA., Baskaya MK; Department of Neurological Surgery, University of Wisconsin, Madison, Wisconsin, USA., Howard SP; Department of Human Oncology, University of Wisconsin, Madison, Wisconsin, USA., Robins HI; Department of Medicine, Division of Hematology, Medical Oncology, and Palliative Care, University of Wisconsin, Madison, Wisconsin, USA.
Source: Neuro-oncology advances [Neurooncol Adv] 2022 Apr 13; Vol. 4 (1), pp. vdac046. Date of Electronic Publication: 2022 Apr 13 (Print Publication: 2022).
Publication Type: Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2632-2498
DOI:10.1093/noajnl/vdac046